124 related articles for article (PubMed ID: 15114428)
61. Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.
Marin S; Martin Val A; Bosch Peligero M; Rodríguez-Bernuz C; Pérez-Ricart A; Vilaró Jaques L; Paredes R; Roca J; Quiñones C
Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631460
[TBL] [Abstract][Full Text] [Related]
62. The toxic effects of chloroquine and hydroxychloroquine on skeletal muscle: a systematic review and meta-analysis.
Biguetti CC; Junior JFS; Fiedler MW; Marrelli MT; Brotto M
Sci Rep; 2021 Mar; 11(1):6589. PubMed ID: 33758324
[TBL] [Abstract][Full Text] [Related]
63. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
[TBL] [Abstract][Full Text] [Related]
64. Under-reporting of adverse drug reactions : a systematic review.
Hazell L; Shakir SA
Drug Saf; 2006; 29(5):385-96. PubMed ID: 16689555
[TBL] [Abstract][Full Text] [Related]
65. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
66. [Muscle problems due to statins: underestimated].
Janssen SP; Smulders YM; Gerdes VE; Visseren FL
Ned Tijdschr Geneeskd; 2010; 154():A1684. PubMed ID: 21435278
[TBL] [Abstract][Full Text] [Related]
67. Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals.
Dugué A; Bagheri H; Lapeyre-Mestre M; Tournamille JF; Sailler L; Dedieu G; Salvayre R; Thouvenot JP; Massip P; Montastruc JL
Eur J Clin Pharmacol; 2004 Jun; 60(4):285-92. PubMed ID: 15114428
[TBL] [Abstract][Full Text] [Related]
68. Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals.
Tavassoli N; Duchayne E; Sadaba B; Desboeuf K; Sommet A; Lapeyre-Mestre M; Muoz MJ; Sie P; Honorato J; Montastruc JL; Bagheri H
Eur J Clin Pharmacol; 2007 Mar; 63(3):221-8. PubMed ID: 17225990
[TBL] [Abstract][Full Text] [Related]
69. Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals.
Bagheri H; Michel F; Lapeyre-Mestre M; Lagier E; Cambus JP; Valdiguié P; Montastruc JL
Br J Clin Pharmacol; 2000 Nov; 50(5):479-84. PubMed ID: 11069443
[TBL] [Abstract][Full Text] [Related]
70. Incidence, characteristics, and risk factors of drug-associated muscle adverse reaction: a retrospective real-world study of inpatients.
Zhao A; Guo D; Zhu M; Gao A; Li P; Fu A
Eur J Clin Pharmacol; 2024 Jun; 80(6):911-918. PubMed ID: 38441574
[TBL] [Abstract][Full Text] [Related]
71. Development and validation of algorithms for the detection of statin myopathy signals from electronic medical records.
Chan SL; Tham MY; Tan SH; Loke C; Foo B; Fan Y; Ang PS; Brunham LR; Sung C
Clin Pharmacol Ther; 2017 May; 101(5):667-674. PubMed ID: 27706800
[TBL] [Abstract][Full Text] [Related]
72. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
73. Drug-induced myopathies.
Bannwarth B
Expert Opin Drug Saf; 2002 May; 1(1):65-70. PubMed ID: 12904161
[TBL] [Abstract][Full Text] [Related]
74. Statin-associated myopathy.
Thompson PD; Clarkson P; Karas RH
JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
[TBL] [Abstract][Full Text] [Related]
75. Iatrogenic and toxic myopathies.
Sieb JP; Gillessen T
Muscle Nerve; 2003 Feb; 27(2):142-56. PubMed ID: 12548521
[TBL] [Abstract][Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
